Expert Review of Pharmacoeconomics & Outcomes Research, Volume 24, Issue 3 (2024)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Review of Pharmacoeconomics & Outcomes Research, Volume 24, Issue 3 (2024)

See all volumes and issues
Volume 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Editorial

Editorial
The economic impact of pharmacist intervention during pandemics
Ahmad Z. Al Meslamani & Anan S. Jarab
Pages: 323-326
Published online: 24 Nov 2023
First Page PreviewforThe economic impact of pharmacist intervention during pandemics | Full Text | References | PDF (165.9 KB) | EPUB
  • 400 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Editorial
How should we measure the use of social care and informal care?
Joanna Thorn & Kirsty Garfield
Pages: 327-329
Published online: 26 Jan 2024
First Page PreviewforHow should we measure the use of social care and informal care? | Full Text | References | PDF (148.7 KB) | EPUB
  • 235 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Perspective

Adapting Health Technology Assessment agency standards for surrogate outcomes in early stage cancer trials: what needs to happen?
Kristian Thorlund, Cal Shephard, Lisa Machado, Tara Bourgouin, Lorraine Hudson, Eon Ting, William Dempster & Robert Bick
Pages: 331-342
Published online: 09 Jan 2024
AbstractforAdapting Health Technology Assessment agency standards for surrogate outcomes in early stage cancer trials: what needs to happen? | Full Text | References | PDF (1,019 KB) | EPUB
  • 1252 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Economic and humanistic burden in kidney transplant rejection: a literature review
Emily Moss, Anita Burrell, James Lee, Dawn Reichenbach, Sarah Mitchell, Songkai Yan & Kris Thiruvillakkat
Pages: 343-352
Published online: 29 Jan 2024
AbstractforEconomic and humanistic burden in kidney transplant rejection: a literature review | Full Text | References | PDF (3.9 MB) | EPUB | Supplemental
  • 656 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Meta-analysis

Review Article
Meta-analysis of traditional Chinese medicine on chronic kidney disease
Xian-Ya Wang, Shu-Hua Zhao, An-Na Wang & Di Zou
Pages: 353-359
Published online: 09 Feb 2024
AbstractforMeta-analysis of traditional Chinese medicine on chronic kidney disease | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 94 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Research

Article
Cost-effectiveness analysis of dupilumab versus omalizumab, mepolizumab, and benralizumab added to the standard of care in adults with severe asthma in Colombia
Abraham Ali, Elizabeth García, Carlos A Torres-Duque, Diana Rey, Laura Botero, Stid Saenz, Maria Paula Avila, Elizabeth Mazo & Sergio Londoño
Pages: 361-374
Published online: 01 Feb 2024
AbstractforCost-effectiveness analysis of dupilumab versus omalizumab, mepolizumab, and benralizumab added to the standard of care in adults with severe asthma in Colombia | Full Text | References | PDF (8.9 MB) | EPUB | Supplemental
  • 249 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Lorlatinib as a first-line treatment of adult patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer: Α cost-effectiveness analysis in Greece
George Gourzoulidis, Oresteia Zisimopoulou, Andrianos Liavas & Charalampos Tzanetakos
Pages: 375-385
Published online: 25 Nov 2023
AbstractforLorlatinib as a first-line treatment of adult patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer: Α cost-effectiveness analysis in Greece | Full Text | References | PDF (3.3 MB) | EPUB | Supplemental
  • 189 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Trastuzumab deruxtecan versus chemotherapy treated in patients with HER2-positive metastatic breast cancer: a cost-effectiveness analysis based on the DESTINY-Breast02 trial
Zhiwei Zheng, Hongcai Chen, Hongfu Cai & Siqi Xu
Pages: 387-395
Published online: 06 Dec 2023
AbstractforTrastuzumab deruxtecan versus chemotherapy treated in patients with HER2-positive metastatic breast cancer: a cost-effectiveness analysis based on the DESTINY-Breast02 trial | Full Text | References | PDF (1.7 MB) | EPUB | Supplemental
  • 154 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
First-Line Tislelizumab for Advanced or Metastatic Esophageal Squamous Cell Carcinoma:A Cost-Effectiveness Analysis
Zhiwei Zheng, Hongcai Chen, Hongfu Cai & Huide Zhu
Pages: 397-404
Published online: 06 Dec 2023
AbstractforFirst-Line Tislelizumab for Advanced or Metastatic Esophageal Squamous Cell Carcinoma:A Cost-Effectiveness Analysis | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 121 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Evaluation of Antimicrobial Stewardship Programs and antibiotic prescribing patterns among physicians in ambulatory care settings in Jordan
Mera A. Ababneh, Hana Abujuma, Shoroq Altawalbeh & Saddam Al Demour
Pages: 405-412
Published online: 14 Dec 2023
AbstractforEvaluation of Antimicrobial Stewardship Programs and antibiotic prescribing patterns among physicians in ambulatory care settings in Jordan | Full Text | References | PDF (289.8 KB) | EPUB
  • 67 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Cost-effectiveness analysis of add-on pertuzumab to trastuzumab biosimilar and chemotherapy as neoadjuvant treatment for human epidermal growth receptor 2-positive early breast cancer patients in Singapore
Elaine Hsuen Lim, Andrew Lim, Jasmeet Singh Khara, John Cheong, Jek Fong, Sivabalan Sivanesan, Matt Griffiths, Emma New & Soo Chin Lee
Pages: 413-426
Published online: 30 Jan 2024
AbstractforCost-effectiveness analysis of add-on pertuzumab to trastuzumab biosimilar and chemotherapy as neoadjuvant treatment for human epidermal growth receptor 2-positive early breast cancer patients in Singapore | Full Text | References | PDF (2.4 MB) | EPUB
  • 929 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Direct diabetes-related healthcare expenditures in Slovenia: recent evolution and future projections based on population-level data
Petra Došenović Bonča, Dalibor Gavrić, Karmen Janša & Jože Sambt
Pages: 427-436
Published online: 09 Jan 2024
AbstractforDirect diabetes-related healthcare expenditures in Slovenia: recent evolution and future projections based on population-level data | Full Text | References | PDF (965.9 KB) | EPUB | Supplemental
  • 66 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Fiscal analysis of the pediatric immunization program in Belgium applying a lifetime government perspective framework
Nikos Kotsopoulos, André Bento-Abreu, Goran Bencina & Mark P. Connolly
Pages: 437-445
Published online: 23 Jan 2024
AbstractforFiscal analysis of the pediatric immunization program in Belgium applying a lifetime government perspective framework | Full Text | References | PDF (624.4 KB) | EPUB | Supplemental
  • 524 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Feasibility assessment of using the MiToS staging system for conducting economic evaluation in amyotrophic lateral sclerosis
Paulos Gebrehiwet, Saurabh Aggarwal, Ozlem Topaloglu & Adriano Chiò
Pages: 447-458
Published online: 25 Jan 2024
AbstractforFeasibility assessment of using the MiToS staging system for conducting economic evaluation in amyotrophic lateral sclerosis | Full Text | References | PDF (431.2 KB) | EPUB | Supplemental
  • 595 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Explore articles